phase readout
saveNCT07137481: Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Hematological Malignancies
view source ↗
comments(0)
5-min edit window · permanent after that